Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study

被引:0
作者
Francesco Di Costanzo
Andrea Sdrobolini
Luigi Manzione
Domenico Bilancia
Luigi Acito
Silvia Gasperoni
Lanfranco Valenti
Lorella Fioriti
Sabrina Angiona
Lucio Giustini
机构
[1] University Hospital,Medical Oncology Unit, Department of Internal Medicine and Oncology
[2] General Hospital S. Carlo,Medical Oncology Service
[3] General Hospital A. Murri,Medical Oncology Service
来源
Breast Cancer Research and Treatment | 1999年 / 54卷
关键词
advanced breast cancer; mitoxantrone; paclitaxel;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Paclitaxel and mitoxantrone are highly active agents in the treatment of advanced breast cancer (ABC). This study evaluated the combination of paclitaxel and mitoxantrone in patients with advanced breast cancer to determine activity and toxicity.
引用
收藏
页码:165 / 171
页数:6
相关论文
共 161 条
[1]  
Harris JR(1992)Medical progress: breast cancer N Engl J Med 327 7-1259
[2]  
Lippman ME(1990)The clinical pharmacology of paclitaxel (taxol) Taxol – a novel investigational antimicrotubule agent. J Natl Cancer Inst 82 1247-25
[3]  
Veronesi U(1993)Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer Semin Oncol 20 16-1805
[4]  
Willett W(1991)Paclitaxel (taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines J Natl Cancer Inst 83 1797-33
[5]  
Rowinsky EK(1994)Paclitaxel activity in heavily pre-treated breast cancer: a National Cancer Institute Treatment Referral Center trial Semin Oncol 21 29-2065
[6]  
Cazenave LA(1995)Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion J Clin Oncol 13 2056-1629
[7]  
Donehower RC(1994)Hypersensitivity reactions from taxol J Clin Oncol 12 1621-1268
[8]  
Rowinsky EK(1990)European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high dose versus low dose and long versus short infusion J Clin Oncol 8 1263-2666
[9]  
Donehower RC(1994)Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer J Clin Oncol 12 2654-1867
[10]  
Holmes FA(1996)Paclitaxel by 3 h infusion in combination with bolus Dox in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose finding and sequence-finding study J Clin Oncol 14 1857-2699